M. Helen Thackray

Affiliations

  • Chief R&D Officer at Biocryst Pharmaceuticals Inc (BCRX), 2025-04-02
  • Director at Immunogen Inc. (IMGN), 2024-02-12
  • Svp Clinical Development, Cmo at Glycomimetics Inc (GLYC), 2021-01-22
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
BCRX $5.86 30,000 $175,800.00 272,139 2024-05-14 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
BCRX $8.29 7,000 $58,030.00 207,275 2023-04-03 Filing
BCRX $10.89 3,125 $34,031.25 133,275 2022-12-15 Filing
BCRX $16.20 7,600 $123,120.00 136,400 2022-04-01 Filing
GLYC $15.01 2,000 $30,020.00 148,615 2017-12-08 Filing
GLYC $13.00 2,000 $26,000.00 150,615 2017-09-18 Filing